GW Pharmaceuticals Ltd.
🇬🇧United Kingdom
- Country
- 🇬🇧United Kingdom
- Ownership
- Public, Subsidiary
- Established
- 1998-01-01
- Employees
- 1.1K
- Market Cap
- -
- Website
- http://gwpharm.com
Clinical Trials
10
Active:0
Completed:3
Trial Phases
3 Phases
Phase 1:4
Phase 2:1
Phase 3:5
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (10 trials with phase data)• Click on a phase to view related trials
Phase 3
5 (50.0%)Phase 1
4 (40.0%)Phase 2
1 (10.0%)A Study to Assess the Pharmacokinetic (PK) Properties of Sativex® in Patients With Advanced Cancer
- First Posted Date
- 2015-05-04
- Last Posted Date
- 2016-03-02
- Lead Sponsor
- GW Pharmaceuticals Ltd
- Registration Number
- NCT02432612
A Study to Evaluate the Pharmacokinetics Of Sativex® in Subjects With Severe Renal Impairment or End Stage Renal Disease, Compared to Matched Subjects With Normal Renal Function.
- First Posted Date
- 2014-12-24
- Last Posted Date
- 2016-08-11
- Lead Sponsor
- GW Pharmaceuticals Ltd
- Registration Number
- NCT02325024
A Randomised, Open-label, Three-way Crossover Study to Assess the Pharmacokinetics and Safety of Single Doses of Four Sprays of Sativex® in a Range of Oral pH Environments in Healthy Subjects
- First Posted Date
- 2014-09-15
- Last Posted Date
- 2021-02-05
- Lead Sponsor
- GW Pharmaceuticals Ltd
- Target Recruit Count
- 6
- Registration Number
- NCT02240160
A Pharmacokinetic Study of Single Doses of Sativex in Treatment-induced Mucositis
- First Posted Date
- 2013-11-05
- Last Posted Date
- 2016-08-11
- Lead Sponsor
- GW Pharmaceuticals Ltd
- Target Recruit Count
- 10
- Registration Number
- NCT01975688
- Locations
- 🇬🇧
Quintiles London Drug Research Unit, London, United Kingdom
Sativex® for Relieving Persistent Pain in Participants With Advanced Cancer
- First Posted Date
- 2010-12-17
- Last Posted Date
- 2018-04-23
- Lead Sponsor
- GW Pharmaceuticals Ltd
- Target Recruit Count
- 397
- Registration Number
- NCT01262651
- Prev
- 1
- 2
- Next
News
No news found